5-aminomethylquinoxaline-2,3-diones, Part III: Arylamide derivatives as highly potent and selective glycine-site NMDA receptor antagonists

This publication has 11 references indexed in Scilit:

• Patent Update Central & Peripheral Nervous Systems: Glycine-site NMDA receptor antagonists: an update
  Expert Opinion on Therapeutic Patents, 1996
• Review Central & Peripheral Nervous Systems: Glycine-site NMDA receptor antagonists
  Expert Opinion on Therapeutic Patents, 1995
• The Neuroprotective Effect of the Glycine Site Antagonist 3R-(+)-cis-4-Methyl-HA966 (L-687,414) in a Rat Model of Focal Ischaemia
  Journal of Cerebral Blood Flow & Metabolism, 1995
• Effects of oxcarbazepine and 10-hydroxycarbamazepine on action potential firing and generalized seizures
  European Journal of Pharmacology, 1994
• The Glycine Site on the NMDA Receptor: Structure-Activity Relationships and Therapeutic Potential
  Journal of Medicinal Chemistry, 1994
• The glycine site of the NMDA receptor — five years on
  Trends in Pharmacological Sciences, 1993
• The discriminative stimulus properties of (+)-HA-966, an antagonist at the glycine/N-methyl-D-aspartate receptor
  European Journal of Pharmacology, 1990
• The competitive NMDA receptor antagonists CGP 37849 and CGP 39551 are potent, orally-active anticonvulsants in rodents
  Naunyn-Schmiedebergs Archiv für experimentelle Pathologie und Pharmakologie, 1990
• Synthesis of 4-phosphono- and of 4-(phosphonomethyl)-dl-phenylalanine, two analogues of O-phosphotyrosine
  Tetrahedron, 1990
• The Binding of [³H]AMPA, a Structural Analogue of Glutamic Acid, to Rat Brain Membranes
  Journal of Neurochemistry, 1982